Consider IV Methylprednisolone for the Most Severe Lupus Flares

August 2019

Questions come up about managing patients admitted with systemic lupus erythematosus flares.

Serious flares of this autoimmune disease can present as nephritis, neuropsychiatric changes, vasculitis, thrombocytopenia, etc.

Rule out other illnesses commonly seen in these patients, such as infection or thrombosis.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Table of Contents

Compounding Look for New Risk Categories and Beyond-Use Dates With USP 797
Hemorrhage Know When to Consider Using Topical or Nebulized Tranexamic Acid
Education and Training Be a Stand-Out Residency Preceptor
Insulin Know When Human Insulins Are an Alternative to Pricey Analogs
Lupus Consider IV Methylprednisolone for the Most Severe Lupus Flares
Compounding Be Ready for Non-Sterile Compounding Changes With USP 795 Updates
Diabetes Analyze the Cardiovascular Benefits of the Different GLP-1 Agonists
Opioids Don't Think of Tramadol as a "Safer" Opioid
Cardiology Optimize Meds for Peripheral Artery Disease
Photosensitivity Help Prevent and Manage Med-Induced Photosensitivity
HIV & AIDS Consider HIV a CV "Risk Enhancer"
Patient Safety Tell Patients to Avoid Unsafe Stem Cells
Storage & Disposal Educate Techs and Nurses on New Hazardous Waste Disposal Standards